Geoffrey M Duyk's Net Worth
$21.2 Million
Who is Geoffrey M Duyk?
Geoffrey M Duyk has an estimated net worth of $21.2 Million. This is based on reported shares across multiple companies, which include AMYRIS, INC., EXELIXIS INC, AERIE PHARMACEUTICALS INC, REPLIDYNE INC, and EPIRUS Biopharmaceuticals, Inc..
SEC CIK
Geoffrey M Duyk's CIK is 0001202090
Past Insider Trading and Trends
2003 was Geoffrey M Duyk's most active year for acquiring shares with 5 total transactions. Geoffrey M Duyk's most active month to acquire stocks was the month of July. 2003 was Geoffrey M Duyk's most active year for disposing of shares, totalling 33 transactions. Geoffrey M Duyk's most active month to dispose stocks was the month of September. 2017 saw Geoffrey M Duyk paying a total of $778,131.50 for 58,167 shares, this is the most they've acquired in one year. In 2017 Geoffrey M Duyk cashed out on 116,334 shares for a total of $2,717,739.84, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMYRIS, INC. (AMRSQ) Snapshot price: $0.001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -40.55K |
—
|
—
|
0
|
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
| 120.55K |
Jan 3
| |||
Form 4
| +466.36% | 80K |
—
|
—
| 97.15K |
Aug 22
| |||
Form 4
| +31.63% | 9.74K |
—
|
—
| 40.55K |
Jan 18
| |||
Form 4
| +31.67% | 7.41K |
—
|
—
| 30.81K |
Aug 23
| |||
Form 4
| +69.16% | 9.57K |
—
|
—
| 23.4K |
Aug 5
| |||
Form 4
| +224.24% | 9.57K |
—
|
—
| 13.83K |
Oct 23
| |||
Form 4
| +120.69% | 35K |
—
|
—
| 64K |
Nov 3
| |||
Form 4
| +141.67% | 17K |
—
|
—
| 29K |
Jul 13
| |||
Form 4
| +33.33% | 3K |
—
|
—
| 12K |
Jul 30
| |||
Form 4
| +50.00% | 3K |
—
|
—
| 9K |
Aug 6
| |||
Form 4
| +100.00% | 3K |
—
|
—
| 6K |
Aug 1
| |||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
EXELIXIS INC (EXEL) Snapshot price: $20.205
Pres R&D & CSO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.33% | -3.10K |
$7.73 | -$23,970.73 | 941.36K |
Nov 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 30
| |||
Form 4
| -0.32% | -3.00K |
$7.73 | -$23,190.00 | 944.46K |
Oct 31
| |||
Form 4
| -0.42% | -4.00K |
$7.93 | -$31,717.13 | 947.46K |
Oct 13
| |||
Form 4
| -2.56% | -25.00K |
$7.93 | -$198,183.60 | 951.46K |
Sep 18 - Oct 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AERIE PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$30.05 | -$1,939,608.34 | 3.4K |
Feb 14 - Feb 15
| |||
Form 4
| +100.00% | 1.7K |
—
|
—
| 3.4K |
Jun 8
| |||
Form 4
|
∞
| 1.7K |
—
|
—
| 1.7K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
REPLIDYNE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
EPIRUS Biopharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |